Cargando…

Pneumococcal vaccination in children with underlying conditions

Detalles Bibliográficos
Autores principales:	Principi, Nicola, Esposito, Susanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707661/ http://dx.doi.org/10.1186/1824-7288-41-S2-A59

Ejemplares similares

Use of 13-valent pneumococcal conjugate vaccine in children older than 5 years of age
por: Principi, Nicola, et al.
Publicado: (2014)

Influenza vaccination in pediatric age
por: Esposito, Susanna, et al.
Publicado: (2015)

Tuberculosis in children
por: Esposito, Susanna, et al.
Publicado: (2014)

Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
por: Esposito, Susanna, et al.
Publicado: (2015)

Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines
por: Principi, Nicola, et al.
Publicado: (2016)

Pneumococcal Disease Prevention: Are We on the Right Track?
por: Principi, Nicola, et al.
Publicado: (2021)

Pertussis-Associated Persistent Cough in Previously Vaccinated Children
por: Principi, Nicola, et al.
Publicado: (2017)

Allied health – 3008. Comparison of anti-allergic effect of pneumococcal conjugated vaccine and pneumococcal polysaccharide vaccine in a murine model of house dust mite allergic rhinitis
por: Kim, Soo Whan, et al.
Publicado: (2013)

Clinical and immunological response to pneumococcal vaccination in pediatric systemic lupus erythematosus
por: Rigdon, D, et al.
Publicado: (2012)

Streptococcus pneumoniae colonisation in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine
por: Esposito, Susanna, et al.
Publicado: (2016)

Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age
por: Esposito, Susanna, et al.
Publicado: (2007)

Pneumococcal colonization in older adults
por: Esposito, Susanna, et al.
Publicado: (2016)

Norovirus Vaccine: Priorities for Future Research and Development
por: Esposito, Susanna, et al.
Publicado: (2020)

Kingella kingae infections in children
por: Principi, Nicola, et al.
Publicado: (2015)

Infectious Discitis and Spondylodiscitis in Children
por: Principi, Nicola, et al.
Publicado: (2016)

Immunity, gut microbiota and infection
por: Esposito, Susanna
Publicado: (2014)

Why It Is Important to Develop an Effective and Safe Pediatric COVID-19 Vaccine
por: Principi, Nicola, et al.
Publicado: (2021)

2555. Predicting Risk of Breakthrough Invasive Pneumococcal Disease in Children After 13-Valent Pneumococcal Conjugate Vaccination
por: Yildirim, Melike, et al.
Publicado: (2018)

2707. Non 13-Valent Pneumococcal Conjugate Vaccine Serotypes Predominate as Causes of Pneumococcal Otitis Media in Children
por: Hulten, Kristina G, et al.
Publicado: (2019)

To mask or not to mask children to overcome COVID-19
por: Esposito, Susanna, et al.
Publicado: (2020)

Do Vaccines Have a Role as a Cause of Autoimmune Neurological Syndromes?
por: Principi, Nicola, et al.
Publicado: (2020)

Reasons in favour of universal vaccination campaign against COVID-19 in the pediatric population
por: Principi, Nicola, et al.
Publicado: (2022)

Function of different ICU ventilators under hyperbaric conditions
por: Stahl, W, et al.
Publicado: (1998)

Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2
por: Esposito, Susanna, et al.
Publicado: (2021)

Restrictive Measures for Children During the COVID-19 Pandemic: Are They Scientifically Supported?
por: Principi, Nicola, et al.
Publicado: (2021)

Pneumococcal Pneumonia Vaccination Among Older African American and Hispanic Men With Chronic Conditions
por: Smith, Matthew, et al.
Publicado: (2020)

Work of breathing imposed by different ventilators under hyperbaric conditions
por: Calzia, E, et al.
Publicado: (1998)

Antimicrobial activity of antibiotics in urine under different physiological conditions
por: Burian, Angela, et al.
Publicado: (2010)

2711. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Older Adults
por: Lewis, Ned, et al.
Publicado: (2019)

2701. The Impact of Infant 13-valent Conjugate Pneumococcal Vaccination Program on Invasive Pneumococcal Disease in Children in British Columbia, Canada
por: Vadlamudi, Nirma K, et al.
Publicado: (2019)

Myocarditis Following COVID-19 Vaccine Use: Can It Play a Role for Conditioning Immunization Schedules?
por: Esposito, Susanna, et al.
Publicado: (2022)

Effects of Coronavirus Infections in Children
por: Principi, Nicola, et al.
Publicado: (2010)

2699. Pneumococcal Vaccination During Chemotherapy in Children Treated for Acute Lymphoblastic Leukemia
por: Dorval, Sarah, et al.
Publicado: (2019)

Older adults’ vaccine hesitancy: psychosocial predictors of influenza, pneumococcal, & shingles vaccine uptake
por: Nicholls, Louise Brown, et al.
Publicado: (2020)

Vaccination prevents allergic disorders in children
por: Herbarth, Olf, et al.
Publicado: (2015)

Vaccination risks in children with rare diseases
por: Barberi, Ignazio, et al.
Publicado: (2015)

1430. Evolving Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease
por: Yildirim, Inci, et al.
Publicado: (2018)

2717. The Impact of Pneumococcal Conjugate Vaccine in Nonbacteremic Pneumococcal Pneumonia Among Cancer Patients
por: Lee, Yeon Joo, et al.
Publicado: (2019)

576. Burden of Pneumococcal Disease Due to Serotypes Covered by the 13-Valent and New Higher-Valent Pneumococcal Conjugate Vaccines in All Children and Children at Risk in the United States
por: Huang, Liping, et al.
Publicado: (2022)

Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.
por: Pilishvili, Tamara, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gr0u8ck4q5d16osjekmrbe6818